This Review discusses paradigm shifts in the treatment of hypothyroidism and their influence on clinical practice—a far from trivial issue, given the number of affected patients. Although levothyroxine monotherapy remains the standard treatment for hypothyroidism, the latest guidelines indicate that levothyroxine plus liothyronine combination therapy might be considered in specific circumstances.
